D
Domenico Coppola
Researcher at University of South Florida
Publications - 274
Citations - 11942
Domenico Coppola is an academic researcher from University of South Florida. The author has contributed to research in topics: Cancer & Adenocarcinoma. The author has an hindex of 53, co-authored 274 publications receiving 10713 citations. Previous affiliations of Domenico Coppola include Moffitt Cancer Center.
Papers
More filters
Journal ArticleDOI
First-line chemotherapy with capecitabine and temozolomide in patients with metastatic pancreatic endocrine carcinomas.
Jonathan R. Strosberg,Robert L. Fine,Junsung Choi,Aejaz Nasir,Domenico Coppola,Dung Tsa Chen,James F. Helm,Larry K. Kvols +7 more
TL;DR: In vitro data indicate that the combination of capecitabine and temozolomide is synergistic for induction of apoptosis in neuroendocrine tumor cell lines.
Journal ArticleDOI
MicroRNA-221/222 negatively regulates estrogen receptor α and is associated with tamoxifen resistance in breast cancer
Jian-jun Zhao,Jianhong Lin,Hua Yang,William Kong,Lili He,Xu Ma,Domenico Coppola,Jin Q. Cheng +7 more
TL;DR: Findings indicate thatmiR-221 and miR-222 play a significant role in the regulation of ER α expression at the protein level and could be potential targets for restoring ERα expression and responding to antiestrogen therapy in a subset of breast cancers.
Journal Article
Phosphatidylinositol-3-OH Kinase (PI3K)/AKT2, activated in breast cancer, regulates and is induced by estrogen receptor alpha (ERalpha) via interaction between ERalpha and PI3K.
Mei Sun,June E. Paciga,Richard I. Feldman,Zeng-qiang Yuan,Domenico Coppola,You Yong Lu,Sue A. Shelley,Santo V. Nicosia,Jin Q. Cheng +8 more
TL;DR: Elevated kinase levels of AKT2 and phosphatidylinositol-3-OH kinase (PI3K) in 32 of 80 primary breast carcinomas indicate that regulation between the ERalpha and PI3K/AKT2 pathway may play an important role in pathogenesis of human breast cancer and could contribute to ligand-independent breast cancer cell growth.
Journal ArticleDOI
Molecular Staging for Survival Prediction of Colorectal Cancer Patients
Steven A. Eschrich,Ivana V. Yang,Greg Bloom,Ka Yin Kwong,David Boulware,Alan B. Cantor,Domenico Coppola,Mogens Kruhøffer,Lauri A. Aaltonen,Torben F. Ørntoft,John Quackenbush,Timothy J. Yeatman +11 more
TL;DR: Molecular staging identifies patient prognosis more accurately than the traditional clinical staging, particularly for intermediate Dukes' stage B and C patients, with the potential to direct adjuvant therapy.
Journal ArticleDOI
MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer.
William Kong,Lili He,Marc Coppola,Jianping Guo,Nicole N. Esposito,Domenico Coppola,Jin Q. Cheng +6 more
TL;DR: Evidence is presented that miR-155 is a critical therapeutic target in breast cancer because of its role in regulation of cell survival and chemosensitivity through down-regulation of FOXO3a in breast cancers.